Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on: June 04,2024 8

Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on:June 04,2024 8

Researchers convert pro-tumor macrophages into cancer killers

by University of California - San DiegoCredit: CC0 Public DomainEpithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer ther

Updated on: June 15,2024 5

Researchers convert pro-tumor macrophages into cancer killers

by University of California - San DiegoCredit: CC0 Public DomainEpithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer ther

Updated on:June 15,2024 5

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024 19

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024 19

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

by Society of Nuclear MedicineA radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detecte

Updated on: April 06,2024 0

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

by Society of Nuclear MedicineA radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detecte

Updated on:April 06,2024 0

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Updated on: March 01,2024 12

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Updated on:March 01,2024 12

Fake organs guide the way for 'impossible' cancer surgery

by Mark Michaud,University of Rochester Medical CenterAhmed Ghazi, M.D., holds a lifelike model of Anthony Camnetar's kidney. Credit: University of Rochester Medical CenterAnthony Camnetar r

Updated on: March 06,2024 20

Fake organs guide the way for 'impossible' cancer surgery

by Mark Michaud,University of Rochester Medical CenterAhmed Ghazi, M.D., holds a lifelike model of Anthony Camnetar's kidney. Credit: University of Rochester Medical CenterAnthony Camnetar r

Updated on:March 06,2024 20

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024 0

Genetic test improves clinical care for children with cancer in England

byWellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainWhole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care

Updated on: July 05,2024 0

Genetic test improves clinical care for children with cancer in England

byWellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainWhole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care

Updated on:July 05,2024 0

Researchers improve classification of pancreatic cancer to better predict patient outcomes

by Katie Sullivan,University of TorontoSangeetha Kalimuthu, an assistant professor of laboratory medicine and pathobiology at U of T and a gastrointestinal pathologist at UHN, is the co-author o

Updated on: June 15,2024 5

Researchers improve classification of pancreatic cancer to better predict patient outcomes

by Katie Sullivan,University of TorontoSangeetha Kalimuthu, an assistant professor of laboratory medicine and pathobiology at U of T and a gastrointestinal pathologist at UHN, is the co-author o

Updated on:June 15,2024 5

Gray hair and wrinkles at an early age lead researchers to potential new treatment for rare cancer

by University of CopenhagenSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been exami

Updated on: February 18,2024 17

Gray hair and wrinkles at an early age lead researchers to potential new treatment for rare cancer

by University of CopenhagenSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been exami

Updated on:February 18,2024 17

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Updated on: March 01,2024 17

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Updated on:March 01,2024 17

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on: March 30,2024 0

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on:March 30,2024 0